Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates

KJ Ong, M Checchi, L Burns, C Pavitt… - Sexually Transmitted …, 2019 - sti.bmj.com
Background Many economic evaluations of human papillomavirus vaccination should
ideally consider multiple disease outcomes, including anogenital warts, respiratory …

Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the …

RP Insinga, EJ Dasbach, EH Elbasha - Pharmacoeconomics, 2005 - Springer
The anogenital human papillomavirus (HPV) is estimated to be the most commonly
occurring sexually transmitted infection in the US. Comprehensive estimates of the annual …

Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States

V Prabhu, N Kathe, K Saxena, A Walia… - Current Medical …, 2021 - Taylor & Francis
Introduction Human papillomavirus (HPV) cause cancers in a variety of anatomic sites
presenting at various stages of disease. Current economic assessments rely on HPV-related …

[HTML][HTML] The lifetime cost estimation of human papillomavirus-related diseases in China: a modeling study

W Ding, Y Ma, C Ma, DC Malone, A Ma… - Journal of …, 2021 - degruyter.com
Objectives To estimate the lifetime treatment costs of patients with human papillomavirus
(HPV) infection-related diseases in China and to provide cost estimates for the economic …

Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review

E Préaud, N Largeron - Journal of medical economics, 2013 - Taylor & Francis
Objective: Human papillomavirus (HPV) has an important role in the aetiology of a range of
diseases, including cervical, other anogenital, and head and neck cancers, genital warts …

Updated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United States

HW Chesson, E Meites, DU Ekwueme… - Human vaccines & …, 2019 - Taylor & Francis
Estimates of medical care costs for cervical and other cancers associated with human
papillomavirus (HPV) are higher in studies published in recent years than in studies …

Medical care costs associated with genital warts for commercially insured US patients

KR Dahlstrom, S Fu, W Chan, Z Shelal… - …, 2018 - Springer
Introduction Genital warts are caused by infection with human papillomavirus (HPV) and are
associated with significant morbidity. Primary prevention of genital warts is possible through …

Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective

F Lotfi, F Khodabandeh, A Jafari… - Expert Review of …, 2023 - Taylor & Francis
Background Cervical cancer is one of the most common cancers in women, the cause of
which is mostly human papilloma virus (HPV). The aim of this study was to determine the …

Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States

PA Clay, TD Thompson, LE Markowitz, DU Ekwueme… - Vaccine, 2023 - Elsevier
The annual direct medical cost attributable to human papillomavirus (HPV) in the United
States over the period 2004–2007 was estimated at $9.36 billion in 2012 (updated to 2020 …

[HTML][HTML] Resource Use and Cost of Treating Human Papillomavirus–Related Lesions in Japanese Women

A Mizukami, T Kaise, G Van Kriekinge - Value in health regional issues, 2018 - Elsevier
Background Human papillomavirus (HPV) infection is established as a necessary causal
factor in several pathologies including cervical cancer (CC), which recorded over 11,000 …